Lipoprotein a: Extreme Elevation and Genetic Polymorphism Association with Cardiac and Vascular Lesions Evaluated by Computed Tomography
Fuente:
Redalyc
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo científico |
| Lingua: | en |
| Pubblicazione: |
Sociedad Argentina de Cardiología
2017
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1876477608494891008 |
|---|---|
| author | Pablo Corral |
| author_facet | Pablo Corral |
| contents | Lipoprotein a: Extreme Elevation and Genetic Polymorphism Association with Cardiac and Vascular Lesions Evaluated by Computed Tomography Pablo Corral Marcelo RodrÍguez Silvina Quintana Diego Quirós Augusto Sigismondi Medicina Genetic Lipoprotein Polymorphism Hyperlipidemia Vascular Calcification Background: Lipoprotein a [Lp(a)] has a complex structure, similar to low density lipoprotein, associated with one molecule of apoli- poprotein a [apo(a)]. Elevated plasma levels of Lp(a) are related to greater risk of coronary artery disease and calcification of the aortic valve. This risk is mainly determined by genetic factors. Objectives: The aim of this study was to analyze a group of patients with extreme Lp(a) levels [>100 mg/dL] and their association with calcifications of the aortic valve, coronary arteries and thoracic aorta detected by computed tomography scan, and to evaluate three genetic polymorphisms associated with Lp(a) levels and lesions in these three regions. Methods: rs10455872 and rs2048327 polymorphisms were analyzed in 40 patients using high resolution melting and the number of KIV-2 repeats in the LPA gene was evaluated using quantitative PCR. Patient mean age was 52.9 years (37% women) and mean Lp(a)was 170.4 mg/dL. Results: Seventy-five percent of patients (30/40) presented at least one calcification in the computed tomography scan (valves, coro- nary arteries and/or thoracic aorta), and among them, 90% had at least one of the genetic factors associated with Lp(a) pathogenicity. Conclusion: In a group of patients with elevated Lp(a) levels, we found a significant number of cardiovascular thoracic calcifications and genetic determinants associated with different Lp(a) isoforms that could be related with elevated Lp(a)levels and high risk of developing valve or vascular lesions. 2017 artículo científico 0034-7000 https://www.redalyc.org/articulo.oa?id=305350878007 en http://www.redalyc.org/revista.oa?id=3053 Revista Argentina de Cardiología application/pdf Sociedad Argentina de Cardiología Revista Argentina de Cardiología (Argentina) Num.1 Vol.85 |
| format | Artículo científico |
| id | redalyc_305350878007 |
| institution | Redalyc |
| language | en |
| publishDate | 2017 |
| publisher | Sociedad Argentina de Cardiología |
| spellingShingle | Lipoprotein a: Extreme Elevation and Genetic Polymorphism Association with Cardiac and Vascular Lesions Evaluated by Computed Tomography Pablo Corral Medicina Genetic Lipoprotein Polymorphism Hyperlipidemia Vascular Calcification Lipoprotein a: Extreme Elevation and Genetic Polymorphism Association with Cardiac and Vascular Lesions Evaluated by Computed Tomography Pablo Corral Marcelo RodrÍguez Silvina Quintana Diego Quirós Augusto Sigismondi Medicina Genetic Lipoprotein Polymorphism Hyperlipidemia Vascular Calcification Background: Lipoprotein a [Lp(a)] has a complex structure, similar to low density lipoprotein, associated with one molecule of apoli- poprotein a [apo(a)]. Elevated plasma levels of Lp(a) are related to greater risk of coronary artery disease and calcification of the aortic valve. This risk is mainly determined by genetic factors. Objectives: The aim of this study was to analyze a group of patients with extreme Lp(a) levels [>100 mg/dL] and their association with calcifications of the aortic valve, coronary arteries and thoracic aorta detected by computed tomography scan, and to evaluate three genetic polymorphisms associated with Lp(a) levels and lesions in these three regions. Methods: rs10455872 and rs2048327 polymorphisms were analyzed in 40 patients using high resolution melting and the number of KIV-2 repeats in the LPA gene was evaluated using quantitative PCR. Patient mean age was 52.9 years (37% women) and mean Lp(a)was 170.4 mg/dL. Results: Seventy-five percent of patients (30/40) presented at least one calcification in the computed tomography scan (valves, coro- nary arteries and/or thoracic aorta), and among them, 90% had at least one of the genetic factors associated with Lp(a) pathogenicity. Conclusion: In a group of patients with elevated Lp(a) levels, we found a significant number of cardiovascular thoracic calcifications and genetic determinants associated with different Lp(a) isoforms that could be related with elevated Lp(a)levels and high risk of developing valve or vascular lesions. 2017 artículo científico 0034-7000 https://www.redalyc.org/articulo.oa?id=305350878007 en http://www.redalyc.org/revista.oa?id=3053 Revista Argentina de Cardiología application/pdf Sociedad Argentina de Cardiología Revista Argentina de Cardiología (Argentina) Num.1 Vol.85 |
| title | Lipoprotein a: Extreme Elevation and Genetic Polymorphism Association with Cardiac and Vascular Lesions Evaluated by Computed Tomography |
| topic | Medicina Genetic Lipoprotein Polymorphism Hyperlipidemia Vascular Calcification |
| url | https://www.redalyc.org/articulo.oa?id=305350878007 |